SAMBUCUS NIGRA D 4 globules, 10 g

Instructions for use for SAMBUCUS NIGRA D 4 globules, 10 g

Information for use with the article Sambucus Nigra D 4 Globuli: - Indications: Registered homeopathic medicinal product, therefore without therapeutic indication. Warning: This medicinal product contains sucrose (saccharose / sugar). DIRECTIONS FOR USE: - For best results, Sambucus Nigra D 4 must be used as prescribed. - Keep the leaflet. - Ask your doctor or pharmacist if you need any further information or advice. - If your symptoms get worse or do not improve, you must see a doctor in any case. - Please tell your doctor or pharmacist if you notice any side effects. This leaflet contains: 1. WAS IST SAMBUCUS NIGRA D 4 UND WOFÜR WIRD ES USED? - Sambucus Nigra D 4 is a homeopathic medicinal product. Registered homeopathic medicinal product, therefore no therapeutic indication is given. 2. NOTE WAS MÜSSEN SIE VOR DER ANWENDUNG VON SAMBUCUS NIGRA D 4? - Sambucus Nigra D 4 must not be used if you are hypersensitive (allergic) to any of the ingredients. - You should seek medical advice if your symptoms persist, are unclear or are new. - Please inform your doctor or pharmacist if you are using or have recently used other medicines. 3 WIE IST SAMBUCUS NIGRA D 4 TO USE? - The sprinkle pellets should be taken half an hour before or after meals and preferably allowed to dissolve slowly in the mouth. 4 WELCHE NEBENWIRKUNGEN SIND POSSIBLE? - Like all medicines, Sambucus Nigra D 4 can cause side effects, although not everybody gets them. No side effects have been reported so far. 5. HOW TO STORE WIE IST SAMBUCUS NIGRA D 4? - No special storage conditions are required for this medicinal product. Keep medicinal products out of the reach of children. Further information: - Sambucus Nigra D 4 contains the active ingredient Sambucus nigra (homeopathic) and is available in packs containing 10 g of scattered globules. - Manufacturer: DHU-Arzneimittel GmbH & Co. KG, Ottostraße 24, 76227 Karlsruhe. Source: Information in the package leaflet, as of 01/2016